Skip to content
Search:
Search
Facebook page opens in new window
 
ADCS
Alzheimer's Disease Cooperative Study
ADCSADCS
  • About Us
    • About ADCS
    • Meet the Team
    • ADCS Cores
    • ADCS Site Network
    • Intervention Selection Committee (ISC)
    • ADCS Steering Committee
  • Public & Participant Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Clinical Sites
    • Types of Studies
    • Participate in Research
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
    • DONATE
  • Investigator Resources
    • Publications
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • Steering Committee Members
  • Staff Resources
  • About Us
    • About ADCS
    • Meet the Team
    • ADCS Cores
    • ADCS Site Network
    • Intervention Selection Committee (ISC)
    • ADCS Steering Committee
  • Public & Participant Resources
    • About Alzheimer’s Disease
    • AD Resources
    • Clinical Sites
    • Types of Studies
    • Participate in Research
    • Lifestyle Interventions
    • Alzheimer’s Study Quilt Project
    • DONATE
  • Investigator Resources
    • Publications
    • Study Resources
    • Data Sharing
    • Biorepository
    • ADCS Instruments
    • Preliminary Proposals
    • Combination Therapy Call OPEN
  • Steering Committee Members
  • Staff Resources

Daily Archives: October 9, 2017

You are here:
  1. Home
  2. 2017
  3. October
  4. 09

LSD1 Protects Against Hippocampal and Cortical Neurodegeneration

Research NewsBy ADCS AdminOctober 9, 2017

Alan Levey, MD, PhD, Director of Emory’s Alzheimer’s Disease Research Center, commented on the findings making news: “We were amazed to see the accumulation of LSD1 in neurofibrillary tangles in Alzheimer’s, and in TDP-43 aggregates in FTD”  (Published in Nature Communications this week)

Copyright 2017 Regents of the University of California.
Go to Top